Related Experiment Video
Updated: Apr 26, 2026

04:04
Asthma Detection Research Based on Voice Signal Processing and Machine Learning
Published on: July 22, 2025
1.2K
Predicting phenotypes of asthma and eczema with machine learning
BMC Medical Genomics
|August 1, 2014
Summary
Machine learning models can distinguish asthma and wheeze subtypes by analyzing diverse patient data. Complex modeling advances understanding of heterogeneous diseases like asthma and eczema for personalized healthcare.
Area of Science:
- Computational biology
- Clinical informatics
- Precision medicine
Background:
- Asthma, wheeze, and eczema are increasingly recognized as heterogeneous diseases.
- Investigating machine learning (ML) to differentiate clinical subgroups within these conditions is crucial.
- A large, diverse dataset of attributes was used to explore disease manifestations.
Purpose of the Study:
- To assess the predictive capability of various ML methods in classifying asthma, wheeze, and eczema subgroups.
- To determine the extent to which heterogeneous information can be integrated to reveal specific clinical phenotypes.
- To identify novel predictors for conditions like eczema.
Main Methods:
- A cross-sectional study of 554 adults, including general population and asthma cohorts.
- Application of linear and non-linear ML models (e.g., logistic regression, random forests).
- Analysis of a comprehensive attribute set: demographic, clinical, laboratory, genetic (SNPs), and environmental factors.
Main Results:
- Non-linear ML models demonstrated superior sensitivity and specificity for asthma (AUC 84%) and wheeze (AUC 76%), with moderate performance for eczema (AUC 64%).
- Combined allergen sensitization and lung function data were more effective in characterizing asthma than individual factors.
- Genetic markers showed limited predictive power alone; bio-impedance emerged as a potential predictor for eczema.
Conclusions:
- Complex modeling is essential for understanding disease mechanisms and enabling personalized healthcare.
- Future advancements in disease classification and treatment will benefit from incorporating more diverse factors and longitudinal data.
Related Concept Videos
Asthma I: Introduction
84
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
84
Asthma-II: Pathophysiology and Classification
4.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K

